13F HOLDINGS REPORT
Ikarian Capital, LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001420506-23-001082
Total Value
$440.7M
Positions
117
Other Managers
0
Confidential Omitted
No
Holdings (117)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SAREPTA THERAPEUTICS INC | SRPT | 271,300 | $37.4M | 8.48% |
| 2 | SAREPTA THERAPEUTICS INC | SRPT | 205,400 | $28.3M | 6.42% |
| 3 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 380,000 | $20.6M | 4.67% |
| 4 | PROMETHEUS BIOSCIENCES INC | 74349U108 | 125,926 | $13.5M | 3.07% |
| 5 | IMMUNOVANT INC | IMVT | 774,398 | $12.0M | 2.73% |
| 6 | ASTRIA THERAPEUTICS INC | 04635X102 | 869,390 | $11.6M | 2.62% |
| 7 | MERCK & CO INC | MRK | 100,000 | $10.6M | 2.41% |
| 8 | BRIDGEBIO PHARMA INC | BBIO | 594,686 | $9.9M | 2.24% |
| 9 | AXSOME THERAPEUTICS INC | AXSM | 150,000 | $9.3M | 2.10% |
| 10 | AXSOME THERAPEUTICS INC | AXSM | 150,000 | $9.3M | 2.10% |
| 11 | BRIDGEBIO PHARMA INC | BBIO | 549,600 | $9.1M | 2.07% |
| 12 | REATA PHARMACEUTICALS INC | 75615P103 | 100,000 | $9.1M | 2.06% |
| 13 | BIOMEA FUSION INC | BMEA | 291,000 | $9.0M | 2.05% |
| 14 | TERNS PHARMACEUTICALS INC | TERN | 721,341 | $8.5M | 1.94% |
| 15 | VAXCYTE INC | PCVX | 225,000 | $8.4M | 1.91% |
| 16 | INSMED INC | INSM | 485,000 | $8.3M | 1.88% |
| 17 | MORPHIC HLDG INC | 61775R105 | 213,400 | $8.0M | 1.82% |
| 18 | SPDR SER TR | 78464A870 | 100,000 | $7.6M | 1.73% |
| 19 | REATA PHARMACEUTICALS INC | 75615P103 | 80,564 | $7.3M | 1.66% |
| 20 | APELLIS PHARMACEUTICALS INC | APLS | 100,000 | $6.6M | 1.50% |
| 21 | CHINOOK THERAPEUTICS INC | 16961L106 | 283,464 | $6.6M | 1.49% |
| 22 | BIOMEA FUSION INC | BMEA | 210,975 | $6.5M | 1.48% |
| 23 | BELLUS HEALTH INC NEW | 07987C204 | 885,334 | $6.4M | 1.45% |
| 24 | ACLARIS THERAPEUTICS INC | ACRS | 732,000 | $5.9M | 1.34% |
| 25 | XENON PHARMACEUTICALS INC | XENE | 160,486 | $5.7M | 1.30% |
| 26 | BIOHAVEN LTD | BHVN | 402,326 | $5.5M | 1.25% |
| 27 | TRACON PHARMACEUTICALS INC | 89237H209 | 2,765,530 | $5.2M | 1.19% |
| 28 | IVERIC BIO INC | 46583P102 | 213,521 | $5.2M | 1.18% |
| 29 | PROTAGONIST THERAPEUTICS INC | PTGX | 211,400 | $4.9M | 1.10% |
| 30 | PROTAGONIST THERAPEUTICS INC | PTGX | 211,400 | $4.9M | 1.10% |
| 31 | BIOMARIN PHARMACEUTICAL INC | BMRN | 50,000 | $4.9M | 1.10% |
| 32 | ACLARIS THERAPEUTICS INC | ACRS | 589,300 | $4.8M | 1.08% |
| 33 | VERONA PHARMA PLC | 925050106 | 228,677 | $4.6M | 1.04% |
| 34 | ALTIMMUNE INC | ALT | 1,077,200 | $4.5M | 1.03% |
| 35 | BICYCLE THERAPEUTICS PLC | BCYC | 207,112 | $4.4M | 1.00% |
| 36 | AMYLYX PHARMACEUTICALS INC | AMLX | 150,000 | $4.4M | 1.00% |
| 37 | BICYCLE THERAPEUTICS PLC | BCYC | 200,000 | $4.3M | 0.97% |
| 38 | ROIVANT SCIENCES LTD | ROIV | 575,000 | $4.2M | 0.96% |
| 39 | ARCUS BIOSCIENCES INC | RCUS | 230,000 | $4.2M | 0.95% |
| 40 | CELLDEX THERAPEUTICS INC NEW | CLDX | 110,000 | $4.0M | 0.90% |
| 41 | AEROVATE THERAPEUTICS INC | 008064107 | 195,146 | $3.9M | 0.89% |
| 42 | MERUS N V | N5749R100 | 208,650 | $3.8M | 0.87% |
| 43 | CELLDEX THERAPEUTICS INC NEW | CLDX | 106,057 | $3.8M | 0.87% |
| 44 | ALTIMMUNE INC | ALT | 898,600 | $3.8M | 0.86% |
| 45 | SELECT SECTOR SPDR TR | 81369Y209 | 27,469 | $3.6M | 0.81% |
| 46 | INSMED INC | INSM | 200,000 | $3.4M | 0.77% |
| 47 | ALTIMMUNE INC | ALT | 677,300 | $2.9M | 0.65% |
| 48 | BIOVIE INC | BIVIW | 348,556 | $2.8M | 0.64% |
| 49 | ARDELYX INC | ARDX | 578,825 | $2.8M | 0.63% |
| 50 | DECIPHERA PHARMACEUTICALS IN | 24344T101 | 174,510 | $2.7M | 0.61% |
| 51 | KEZAR LIFE SCIENCES INC | KZR | 841,596 | $2.6M | 0.60% |
| 52 | IMMUNOVANT INC | IMVT | 160,300 | $2.5M | 0.56% |
| 53 | BIOXCEL THERAPEUTICS INC | BTAI | 133,014 | $2.5M | 0.56% |
| 54 | ACLARIS THERAPEUTICS INC | ACRS | 300,163 | $2.4M | 0.55% |
| 55 | VENTYX BIOSCIENCES INC | 92332V107 | 65,000 | $2.2M | 0.49% |
| 56 | ESPERION THERAPEUTICS INC NE | ESPR | 1,355,605 | $2.2M | 0.49% |
| 57 | JASPER THERAPEUTICS INC | JSPRW | 1,126,287 | $2.0M | 0.46% |
| 58 | CYTOKINETICS INC | CYTK | 55,666 | $2.0M | 0.44% |
| 59 | AKERO THERAPEUTICS INC | 00973Y108 | 50,000 | $1.9M | 0.43% |
| 60 | MILESTONE PHARMACEUTICALS IN | MIST | 460,416 | $1.8M | 0.41% |
| 61 | MACROGENICS INC | MGNX | 250,000 | $1.8M | 0.41% |
| 62 | MORPHIC HLDG INC | 61775R105 | 45,873 | $1.7M | 0.39% |
| 63 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 192,260 | $1.4M | 0.32% |
| 64 | ARK ETF TR | 00214Q302 | 46,462 | $1.4M | 0.32% |
| 65 | BIOXCEL THERAPEUTICS INC | BTAI | 71,200 | $1.3M | 0.30% |
| 66 | BLUEBIRD BIO INC | 09609G100 | 412,628 | $1.3M | 0.30% |
| 67 | BIOMEA FUSION INC | BMEA | 40,000 | $1.2M | 0.28% |
| 68 | MIRATI THERAPEUTICS INC | 60468T105 | 33,100 | $1.2M | 0.28% |
| 69 | KARYOPHARM THERAPEUTICS INC | KPTI | 300,000 | $1.2M | 0.26% |
| 70 | SAREPTA THERAPEUTICS INC | SRPT | 8,324 | $1.1M | 0.26% |
| 71 | INTERCEPT PHARMACEUTICALS IN | INTR | 85,200 | $1.1M | 0.26% |
| 72 | ACADIA PHARMACEUTICALS INC | ACAD | 60,000 | $1.1M | 0.26% |
| 73 | KALVISTA PHARMACEUTICALS INC | KALV | 140,000 | $1.1M | 0.25% |
| 74 | DELCATH SYS INC | DCTH | 360,569 | $1.1M | 0.24% |
| 75 | OCULAR THERAPEUTIX INC | OCUL | 200,000 | $1.1M | 0.24% |
| 76 | ACUMEN PHARMACEUTICALS INC | ABOS | 254,945 | $1.0M | 0.23% |
| 77 | POINT BIOPHARMA GLOBAL INC | 730541109 | 139,565 | $1.0M | 0.23% |
| 78 | KODIAK SCIENCES INC | KOD | 162,527 | $1.0M | 0.23% |
| 79 | PROQR THRAPEUTICS N V | N71542109 | 472,625 | $1.0M | 0.23% |
| 80 | INVENTIVA SA | IVEVF | 292,599 | $999,202 | 0.23% |
| 81 | ACHIEVE LIFE SCIENCES INC | ACHV | 174,714 | $989,535 | 0.22% |
| 82 | IMMUNIC INC | IMUX | 650,000 | $968,500 | 0.22% |
| 83 | RENEO PHARMACEUTICALS INC | 75974E103 | 155,819 | $931,798 | 0.21% |
| 84 | KRYSTAL BIOTECH INC | KRYS | 10,300 | $824,618 | 0.19% |
| 85 | TYRA BIOSCIENCES INC | TYRA | 48,170 | $774,092 | 0.18% |
| 86 | SAGE THERAPEUTICS INC | 78667J108 | 17,805 | $747,098 | 0.17% |
| 87 | VIKING THERAPEUTICS INC | VKTX | 43,156 | $718,548 | 0.16% |
| 88 | LYRA THERAPEUTICS INC | LYRA | 343,685 | $711,427 | 0.16% |
| 89 | COGENT BIOSCIENCES INC | COGT | 62,766 | $677,246 | 0.15% |
| 90 | BRAINSTORM CELL THERAPEUTICS | BCLI | 189,935 | $626,786 | 0.14% |
| 91 | BIOHAVEN LTD | BHVN | 45,200 | $617,432 | 0.14% |
| 92 | PROTARA THERAPEUTICS INC | TARA | 188,664 | $584,859 | 0.13% |
| 93 | IMMATICS N.V | IMTX | 179,552 | $526,266 | 0.12% |
| 94 | ELEDON PHARMACEUTICALS INC | ELDN | 221,830 | $523,518 | 0.12% |
| 95 | AUTOLUS THERAPEUTICS PLC | AUTL | 260,087 | $478,559 | 0.11% |
| 96 | ASLAN PHARMACEUTICALS LTD | 04522R200 | 164,088 | $475,856 | 0.11% |
| 97 | PTC THERAPEUTICS INC | PTCT | 9,800 | $474,712 | 0.11% |
| 98 | ANEBULO PHARMACEUTICALS INC | ANEB | 156,203 | $462,360 | 0.10% |
| 99 | IMMUNOGEN INC | 45253H101 | 106,600 | $409,344 | 0.09% |
| 100 | CHEMOMAB THERAPEUTICS LTD | CMMB | 236,709 | $342,091 | 0.08% |
| 101 | X4 PHARMACEUTICALS INC | XFOR | 349,133 | $303,745 | 0.07% |
| 102 | AMYLYX PHARMACEUTICALS INC | AMLX | 10,000 | $293,400 | 0.07% |
| 103 | BIOGEN INC | BIIB | 962 | $267,465 | 0.06% |
| 104 | ERYTECH PHARMA | 29604W108 | 248,426 | $252,111 | 0.06% |
| 105 | CONNECT BIOPHARMA HLDGS LTD | CNTB | 219,501 | $219,479 | 0.05% |
| 106 | SYNLOGIC INC | SYBX | 306,757 | $193,871 | 0.04% |
| 107 | ARK ETF TR | 00214Q104 | 4,519 | $182,297 | 0.04% |
| 108 | RELMADA THERAPEUTICS INC | RLMD | 65,491 | $148,010 | 0.03% |
| 109 | BELLICUM PHARMACEUTICALS INC | 079481404 | 448,101 | $147,873 | 0.03% |
| 110 | SPECTRUM PHARMACEUTICALS INC | 84763A108 | 176,980 | $132,735 | 0.03% |
| 111 | GENFIT S A | 372279109 | 32,786 | $131,511 | 0.03% |
| 112 | SATSUMA PHARMACEUTICALS INC | 80405P107 | 136,059 | $95,037 | 0.02% |
| 113 | FINCH THERAPEUTICS GROUP INC | FNCHQ | 237,553 | $93,359 | 0.02% |
| 114 | ROCKET PHARMACEUTICALS INC | RCKTW | 367,112 | $59,985 | 0.01% |
| 115 | MADRIGAL PHARMACEUTICALS INC | MDGL | 75 | $18,170 | 0.00% |
| 116 | CYCLACEL PHARMACEUTICALS INC | 23254L603 | 275,000 | $10,999 | 0.00% |
| 117 | GOSSAMER BIO INC | GOSS | 6,100 | $7,686 | 0.00% |